{"cluster": 20, "subcluster": 28, "abstract_summ": " Most patients with COVID-19 lack antibody to SARS-CoV-2 in the first 10 days of illness while the virus drives disease pathogenesis . Researchers found that using an antibody as a therapeutic agent would augment the antiviral immune response ."}